Cited by 83Genetic and Kidney Cyst DiseasesTGF-β signaling in diseasesSphingolipid Metabolism and Signaling

TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis

Open access
Gencer, Salih, Oleinik, Natalia, Kim, Jisun, Panneer Selvam, Shanmugam, De Palma, Ryan, Dany, Mohammed, Nganga, Rose, Thomas, Raquela J. +3 more·2017·Science Signaling

Abstract

Ceramide forms complexes with Smad7 to inhibit cell migration–associated TGF-β–sonic hedgehog signaling in primary cilia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scisignal.aam7464

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Feedback inhibitors of TGFβ/BMP signaling, including SMAD7 and SMURF1, localize to the ciliary base and restrain excessive signaling from the primary cilium.

    “Conversely, feedback inhibitors of TGFβ/BMP signalling, including SMAD7 and SMURF1 265, 288, localize to the ciliary base 268, 273 and restrain excessive signalling from the primary cilium.”

    From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [273]

    The Discussion (page unavailable) reports that a ceramide–Smad7 complex inhibits TGF-β receptor trafficking and signaling at primary cilia. It does not establish that SMAD7 localizes to the ciliary base, or address SMURF1 or BMP signaling; the Introduction instead describes Smurf2. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • SMURF1 negatively regulates phosphorylation of SMAD1/5/8 at primary cilia to control cell-type specification during in vivo heart development, which in Smurf1−/− mouse embryos is associated with delayed outflow tract septation.

    “Finally, the E3 ubiquitin ligase SMURF1 negatively regulates phosphorylation of SMAD1/5/8 at primary cilia to control cell-type specification during in vivo heart development, which in Smurf1−/− mouse embryos is associated with delayed outflow tract septation 273.”

    From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [273]

    The Results section on ciliary trafficking addresses CerS4, Smad7, TGF-β receptors, and cancer-cell migration, not SMURF1 regulation of SMAD1/5/8 during heart development. Searches for SMURF1, Smurf1−/− embryos, and outflow tract septation found no passage addressing the claim. The available passages have no page numbers. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 83

Authors
Gencer, S., Oleinik, N., Kim, J., Panneer Selvam, S., De Palma, R., Dany, M., Nganga, R., Thomas, R. J., Senkal, C. E., Howe, P. H., & Ogretmen, B.
Affiliations
  • Medical University of South Carolina (US)
  • Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 125 Ashley Avenue, Charleston, SC 29425, USA.
Corresponding author
  • Gencer, Salih
  • Oleinik, Natalia
Venue
Science Signaling
Published
2017-10-24
Volume
10
Issue
502
ISSN
  • 1937-9145 (ISSN-L)
  • 1945-0877
OpenAlex
W2766486963
Cited by
83
References
70
Citations by year
2026: 5 · 2025: 6 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 14 · 2020: 9 · 2019: 9 · 2018: 6
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • Science Signaling (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (award336702, CA088932, award336703, CA173687, award336704, CA203628)
  • National Institute of Dental and Craniofacial Research (award336701, DE016572)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
TGF-beta type I receptor, TGFBR2, primary cilia, ceramide, Sonic hedgehog signaling, Smoothened, Smad7, IFT88, cell migration, metastasis, liver metastasis, breast cancer, 4T1 cells, receptor trafficking
MeSH terms
A549 Cells, Animals, Cell Movement, Ceramides, Cilia, Disease Models, Animal, Humans, Neoplasm Metastasis, Receptors, Transforming Growth Factor beta, Mice, Knockout, Cell Line, Tumor, Cell Proliferation, Sphingosine N-Acyltransferase, Mice, Smad7 Protein, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review